Next meeting: Lisbon 2025 Registration

Luc Barvais

Not surprisingly, Luc Barvais from the Erasme University in Bruxelles was the initiator of the development of a local Target Controlled Infusion (TCI) system.  He made a major contribution to the teaching of TCI with the very frequently cited and downloaded publication. We encourage you to take notice from this downloadable publication.

Tips-and-Tricks-Acta-2013

From TCI Luc went on to other interesting aspects connected to intravenous anaesthesia: measuring the analgesic component of IV anaesthesia. You can here download a yet unpublished manuscript on the Nociception-Antinociception balance.

The clinical evaluation and validation of the Nociception Level Index was done in the following  publication.
Some further enlightments on the topic can be downloaded here where the effect of Dexmedetomidine on the requirements for remifentanil and propofol is investigated using the Nociception Level Index

Possibly the next development in anaesthesia for the next decade is the development of closeloop anaesthesia. The team at the Erasme Hospital from the Universite Libre in Bruxelles in cooperation with partners made recently some major progress in that direction as you can see in these downloadable publications.

Share the Post:

Related Posts

Wintermeeting 2024: Hernan Boveri

Lost in LOC. Titrating to effect. What does it reveal? Dr. Hernán Boveri, Italian Hospital of Buenos Aires, Argentina. Saturday 20 January 9:00-9:30 Currently, propofol is the most widely used intravenous anesthetic drug capable of providing safe general anesthesia. Propofol can be administered using different techniques including target-controlled infusion (TCI).One of the greatest strengths of TCI technology lies in its ability to maintain the pharmacological condition once the predefined clinical effect has been achieved. TCI models were developed based on

Read More

Wintermeeting 2024 : Stefan Schraag

The different models implemented in TCI:how it happend and who is responsible Stefan Schraag Saturday 10:30-11:00 Who safeguards PK models? It is a tricky task for most to develop a pharmacokinetic model. It gets even more difficult to publish one without any typos. And then, once you have achieved that, what to do with it and how? This is one of the questions surrounding the governance  of pharmacokinetic and pharmacodynamic research and scientific output when it informs medical device development

Read More

Join Our Newsletter

Please enable JavaScript in your browser to complete this form.
Scroll al inicio

This website collects cookies to deliver better user experience